Clinical Trial Update: A Comparative Study of Pravastatin vs Placebo as Primary Prevention of Severe Subcutaneous Breast Fibrosis in Hyper-radiosensitive Identified Patients With Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing pravastatin to placebo for primary prevention of severe subcutaneous breast fibrosis in hyper-radiosensitive breast cancer patients ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pravastatin (pravastatin)

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Breast Cancer | Phase 3 | Status: TERMINATED